MOFFITT CANCER CENTERGUIDE FORREFERRINGPHYSICIANS2012CLOSER TO OUR PATIENTS.CLOSER TO A CURE.™
Ab out M offittH. Lee Moffitt Cancer Center & ResearchInstitute is internationally recognized forits focus on patient care...
M essag e Fro mThe P res id ent,M offitt Med ical G ro u pDear Colleague,This Guide for Referring Physicians has been deve...
Ta b l e O f Co nte nts                            How To Refer A Patient	                                      5         ...
HOW TO REFER A PATIENTTO M OFF IT T CANC E R CE N T E RTo refer a patient to a specific physician, program or service,call...
M offitt Can cer Center Ad d s Lo ca ti o n    N ear Inter n at io n al P la za    The opening of Moffitt Cancer Center ne...
MOFFITT.org   7
B LOOD AN D MAR ROW T RA N S PL A N T PRO G RA M                        D E PA R T M E N T C H A I R A N D                ...
Th e Ce nte r For Wom e n’s O n co lo g y :DON AND ERIKA WALLACE COMPREHENSIVE BREAST PROGRAM                 DIRECTOR, TH...
CU TANEO U S O NCO LO GY PRO G RA M                      D E PA R T M E N T C H A I R A N D                      PROGRAM L...
EN DOC RIN E T U MO R P RO G RA M                     PROGRAM LEADER                     W. Bradford Carter, MD, FACS, FAC...
GASTROINT EST INAL O N CO LO GY PRO G RA M                        D E PA R T M E N T C H A I R A N D                      ...
G ENITOUR INA RY O NCO LO GY PRO G RA M                  D E PA RT M E N T C H A I R A N D                  PROGRAM LEADER...
Th e Ce nte r For Wom e n’s O n co lo g y :     GY NECO LOGIC ONCOLOGY P RO GRA M                        D E PA RT M E N T...
H EA D AND NEC K O NCO LO GY PRO G RA M                       PROGRAM LEADER                       Thomas V. McCaffrey, MD...
IN TE RNAL A ND HOS P I TA L M E D I CI N E PRO G RA M                       PROGRAM LEADER                       Debra L....
M A L IGNA NT HE MATO LO GY PRO G RA M                 D E PA RT M E N T C H A I R A N D                 PROGRAM LEADER   ...
N EURO-O NCO LO GY P RO G RA M                       D E PA RT M E N T C H A I R A N D                       PROGRAM LEADE...
PSYC HOSO C IAL A ND PA L L I AT I V E CA RE PRO G RAM                       PROGRAM LEADER                       Bryan A....
RA D IATIO N O NCO LO GY D E PA RT M E N T                   D E PA R T M E N T C H A I R                   [ Craig W. Ste...
Http  _moffittcancercenter.com_object_render.aspx_path=_contentstore_referring physicans guide_web
Http  _moffittcancercenter.com_object_render.aspx_path=_contentstore_referring physicans guide_web
Http  _moffittcancercenter.com_object_render.aspx_path=_contentstore_referring physicans guide_web
Http  _moffittcancercenter.com_object_render.aspx_path=_contentstore_referring physicans guide_web
Http  _moffittcancercenter.com_object_render.aspx_path=_contentstore_referring physicans guide_web
Http  _moffittcancercenter.com_object_render.aspx_path=_contentstore_referring physicans guide_web
Http  _moffittcancercenter.com_object_render.aspx_path=_contentstore_referring physicans guide_web
Http  _moffittcancercenter.com_object_render.aspx_path=_contentstore_referring physicans guide_web
Http  _moffittcancercenter.com_object_render.aspx_path=_contentstore_referring physicans guide_web
Http  _moffittcancercenter.com_object_render.aspx_path=_contentstore_referring physicans guide_web
Http  _moffittcancercenter.com_object_render.aspx_path=_contentstore_referring physicans guide_web
Http  _moffittcancercenter.com_object_render.aspx_path=_contentstore_referring physicans guide_web
Http  _moffittcancercenter.com_object_render.aspx_path=_contentstore_referring physicans guide_web
Http  _moffittcancercenter.com_object_render.aspx_path=_contentstore_referring physicans guide_web
Http  _moffittcancercenter.com_object_render.aspx_path=_contentstore_referring physicans guide_web
Http  _moffittcancercenter.com_object_render.aspx_path=_contentstore_referring physicans guide_web
Http  _moffittcancercenter.com_object_render.aspx_path=_contentstore_referring physicans guide_web
Http  _moffittcancercenter.com_object_render.aspx_path=_contentstore_referring physicans guide_web
Http  _moffittcancercenter.com_object_render.aspx_path=_contentstore_referring physicans guide_web
Http  _moffittcancercenter.com_object_render.aspx_path=_contentstore_referring physicans guide_web
Http  _moffittcancercenter.com_object_render.aspx_path=_contentstore_referring physicans guide_web
Http  _moffittcancercenter.com_object_render.aspx_path=_contentstore_referring physicans guide_web
Http  _moffittcancercenter.com_object_render.aspx_path=_contentstore_referring physicans guide_web
Http  _moffittcancercenter.com_object_render.aspx_path=_contentstore_referring physicans guide_web
Upcoming SlideShare
Loading in …5
×

Http _moffittcancercenter.com_object_render.aspx_path=_contentstore_referring physicans guide_web

1,931 views

Published on

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
1,931
On SlideShare
0
From Embeds
0
Number of Embeds
3
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Http _moffittcancercenter.com_object_render.aspx_path=_contentstore_referring physicans guide_web

  1. 1. MOFFITT CANCER CENTERGUIDE FORREFERRINGPHYSICIANS2012CLOSER TO OUR PATIENTS.CLOSER TO A CURE.™
  2. 2. Ab out M offittH. Lee Moffitt Cancer Center & ResearchInstitute is internationally recognized forits focus on patient care and translationalresearch. For patients, that means acollaborative, all-encompassing circle ofcare that looks at each individual as a wholeperson. Behind the scenes, physicians,scientists and other cancer care specialistswork to translate research discoveries fromthe bench to the bedside – using those laboratory advances to improve patient care.As part of a National Cancer Institute Comprehensive Cancer Center, team members work tirelessly in the areas of patientcare, research and education to constantly advance in our fight against this disease. Our goal is to ensure that all of ourpatients – throughout the state of Florida and beyond – have increased access to cutting-edge research protocols that focuson the prevention and cure of cancer. MO FFIT T.org To access the Guide for Referring Physicians online: http://www.moffitt.org/medicalprofessionals 12902 Magnolia Drive | Tampa, FL 33612 | 1-888-MOFFITT­(1-888-663-3488) H. LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE, AN NCI COMPREHENSIVE CANCER CENTER – Tampa, FL © 2011 H. Lee Moffitt Cancer Center and Research Institute, Inc
  3. 3. M essag e Fro mThe P res id ent,M offitt Med ical G ro u pDear Colleague,This Guide for Referring Physicians has been developed to assist you in accessing theresources and services at the H. Lee Moffitt Cancer Center & Research Institute that areavailable to you and your patients.Moffitt Medical Group physicians, scientists, and staff members continue to fight on all frontsto “contribute to the prevention and cure of cancer,” which is Moffitt’s mission. We considerit a privilege to participate in the care of your patients, and it is our goal to complement theservices you provide in the community.At Moffitt Cancer Center, our clinical services have been organized into disease-orientedinterdisciplinary programs. This guide contains overviews of Moffitt’s clinical programs andservices and information on how to contact each program.We hope you find this directory useful, and we invite you to call on the clinical, research andeducational resources at Moffitt Cancer Center. If you have questions or concerns that are notbeing addressed by our faculty or staff, please do not hesitate to call me at 813-745-6086.Alan F. List, MDExecutive Vice President, Clinical SciencesPhysician-In-ChiefPresident, Moffitt Medical Group 3
  4. 4. Ta b l e O f Co nte nts How To Refer A Patient 5 Moffitt Cancer Center Adds Location Near International Plaza 6 Interdisciplinary Clinical Programs And Services: Blood And Marrow Transplant Program 8 Breast Program 9 Cutaneous Oncology Program 10 Endocrine Tumor Program 11 Gastrointestinal Oncology Program 12 Genitourinary Oncology Program 13 Gynecologic Oncology Program 14 Head And Neck Oncology Program 15 Internal And Hospital Medicine Program 16 Malignant Hematology Program 17 Neuro-Oncology Program 18 Psychosocial And Palliative Care Program 19 Radiation Oncology Department 20 Sarcoma Program 21 Senior Adult Oncology Program 22 Survivorship Program 23 Thoracic Oncology Program 24 Interdisciplinary Clinical Services: Diagnostic Imaging, Body Imaging, Breast Imaging And Nuclear Medicine 25 Interventional Radiology Services 26 Neuroradiology Services 27 Pathology Services 28 Interventional Pain Medicine Service 29 Cancer Prevention 30 Total Cancer Care™ – An Overview 31 Total Cancer Care™ Consortium 32 Medical Staff Index 33 Directions to Moffitt BACK COVER4 Moffitt Medical Group
  5. 5. HOW TO REFER A PATIENTTO M OFF IT T CANC E R CE N T E RTo refer a patient to a specific physician, program or service,call the New Patient Appointment Center at 813-745-3980 or1-888-860-2778, Mon-Fri, 8:00 am - 5:00 pm.If you need assistance identifying the best physician for your patientor have questions about Moffitt Cancer Center’s programs and services,call our Physician Resource Line at 1-888-MOFFITT.To determine if a Moffitt clinical trial is available for your patient,call 813-745-4106 or visit www.MOFFITT.org.To refer an international patient, please call our International RelationsDepartment at 813-745-3571 or 813-745-4216.> Key Telephone Numbers Moffitt Cancer Center............................................................. 813-745-4673 800-456-3434 Physician Resource Line........................................................888-MOFFITT New Patient Appointment Center......................................... 813-745-3980 Mon-Fri, 8:00 am - 5:00 pm 888-860-2778 Lifetime Cancer Screening & Prevention Center............... 813-745-6769 Clinical Trials Office................................................................ 813-745-4106 Cancer Answers...................................................................... 800-456-7121 888-MOFFITT Pharmacy. ............................................................................... 813-745-8485 . Patient Relations.................................................................... 813-745-3808 International Relations............................................................ 813-745-3571 or 813-745-4216 Web Site............................................................................ www.MOFFITT.org MOFFITT.org 5
  6. 6. M offitt Can cer Center Ad d s Lo ca ti o n N ear Inter n at io n al P la za The opening of Moffitt Cancer Center near International Plaza and the Tampa International Airport allows Moffitt to provide expanded services that are easily accessible to more patients. Just as at Moffitt’s main facility on the University of South Florida campus, Moffitt’s outpatient center located near International Plaza gives patients the opportunity to participate in clinical trials and translational research studies. Hillsborough Ave. Services at the International Plaza location include: Dale Mabry Highway Veterans Expressway • oncology physician practice office visits for Tampa International Airport medical, surgical and radiation oncology Raymond James Stadium • infusion services (24 private chemotherapy Moffitt Cancer Center at International Plaza infusion bays) Jim Walter Blvd. Columbus Dr. International d. Blv • blood draw area and clinical laboratory Plaza ut Getting to o Sc Spruce St. B oy Westshore Blvd. • radiation therapy Moffitt Cancer Lois Ave. • radiology (PET, CT, MRI, chest x-ray and Center’s Facility mammography/ultrasound) At International Kennedy Blvd. Moffitt Cancer Center at International Plaza is Plaza located at 4101 Jim Walter Blvd., Tampa, FL 33607. Located in south Tampa, our satellite facility is adjacent to International Phone: 813-745-1600 Plaza, on the east side of the Tampa International Airport property. The operating hours are scheduled for 7:00 a.m. to I-4 west, merge onto I-275 south towards St. Petersburg. Then 5:00 p.m., Monday through Friday, with the ability follow 1-275 directions. to expand hours during weekdays and Saturdays in I-75 south, merge onto I-275 south towards St. Petersburg. Then the future. follow 1-275 directions. I-275, traveling north or south, take exit 41B onto Dale Mabry Physicians who also see patients at Moffitt Cancer Highway northbound and continue to Columbus Drive. Turn left onto Center’s satellite location near International Plaza Columbus Drive and proceed west. Turn right at the first traffic light are marked with an asterisk ([ ) in this directory. onto Jim Walter Boulevard. You will see the Center’s main entrance immediately on your right. Veterans Expressway traveling south, continue on to FL-60 east. Take exit 1B for Spruce Street toward Raymond James Stadium. Merge onto West Spruce Street and continue onto Boy Scout Boulevard. Turn left onto Jim Walter Boulevard. You will see the Center’s main entrance immediately on your right.6 Moffitt Medical Group
  7. 7. MOFFITT.org 7
  8. 8. B LOOD AN D MAR ROW T RA N S PL A N T PRO G RA M D E PA R T M E N T C H A I R A N D PROGRAM LEADER Overview Claudio Anasetti, MD Medical Oncology The Blood and Marrow Transplant (BMT) Program 813-745-2557 opened at Moffitt Cancer Center in 1989. The Cancer claudio.anasetti@moffitt.org Center’s BMT Program is now one of the largest in the United States, performing more than 350 transplants a year. More than 500 transplant-related admissions and MEDICAL ONCOLOGISTS Lia E. Perez, MD over 13,000 clinic visits to BMT medical providers occur A N D H E M AT O L O G I S T S Hematology annually. Moffitt’s BMT Program is accredited by FACT Melissa Alsina, MD 813-745-2557 (Foundation for the Accreditation of Cellular Therapies). Hematology lia.perez@moffitt.org The BMT Program offers autologous, related and Head, Multiple Myeloma Joseph Pidala, MD, MS unrelated allogeneic blood and marrow stem cell and Transplant Program Medical Oncology 813-745-7202 umbilical cord blood transplantation for a variety 813-745-6012 melissa.alsina@moffitt.org of hematologic and oncologic disorders, including joseph.pidala@moffitt.org leukemia, lymphoma, multiple myeloma, myelodysplasia, Claudio Anasetti, MD Daniel Sullivan, MD Medical Oncology aplastic anemia and selected solid tumors. Data are Medical Oncology 813-745-2557 Executive Vice President/ reported to the National Marrow Donor Program and claudio.anasetti@moffitt.org Associate Center Director, the Center for International Bone Marrow Transplant Ernesto Ayala, MD Clinical Investigations Research. Medical Oncology, Hematology 813-745-3878 The BMT Program includes an interdisciplinary team 813-745-8248 dan.sullivan@moffitt.org of BMT-trained physicians, physician assistants, nurse ernesto.ayala@moffitt.org Marcie Tomblyn, MD, MS practitioners, nurses, pharmacists, social workers, Brian C. Betts, MD Medical Oncology, Hematology dietitians, and laboratory personnel. An outpatient Medical Oncology, Hematology 813-745-7202 center provides pre-transplant evaluation and post- 813-745-7202 marcie.tomblyn@moffitt.org transplant follow-up care. brian.betts@moffitt.org William S. Dalton, PhD, MD OTHER SPECIALISTS Research Medical Oncology President/CEO and Center Director John N. Greene, MD Ongoing studies are directed at improving the 813-745-4261 Infectious Diseases efficacy of autologous stem cell transplantation, william.dalton@moffitt.org 813-745-8408 decreasing morbidity by lowering the intensity of the john.greene@moffitt.org Hugo F. Fernandez, MD conditioning regimen before related and unrelated Hematology transplantation,and improving the prevention and 813-745-6012 treatment of graft-versus-host disease. hugo.fernandez@moffitt.org Teresa L. Field, MD, PhD Hematology 813-745-8248 teresa.field@moffitt.org Frederick Locke, MD Medical Oncology 813-745-8248 frederick.locke@moffitt.org Taiga Nishihori, MD Medical Oncology, Hematology 813-745-7202 taiga.nishihori@moffitt.org José Leonel Ochoa-Bayona, MD Medical Oncology, Hematology 813-745-7202 leonel.ochoa@moffitt.org [ THESE PHYSICIANS ALSO SEE PATIENTS AT MOFFITT CANCER CENTER’S SATELLITE LOCATION NEAR INTERNATIONAL PLAZA. To refer patients for BMT: 813-745-8751 or 813-745-8530 To refer a patient: 813-745-3980 or 1-888-860-2778, Mon-Fri, 8:00 am - 5:00 pm Information about clinical trials: 813-745-41068 Moffitt Medical Group
  9. 9. Th e Ce nte r For Wom e n’s O n co lo g y :DON AND ERIKA WALLACE COMPREHENSIVE BREAST PROGRAM DIRECTOR, THE CENTER FOR WOMEN’S ONCOLOGY Johnathan M. Lancaster, MD, PhD, FACS, FACOG Overview Women’s Oncology and Gynecologic Oncology 813-745-6300 Moffitt’s Don and Erika Wallace Comprehensive Breast johnathan.lancaster@moffitt.org Program offers a team approach for the prevention, diagnosis and treatment of breast cancer in men and women. As part of The Center for Women’s Oncology at Moffitt, services are provided with an interdisciplinarySURGEONS MEDICAL ONCOLOGISTS approach to deliver the most advanced care for patients[ Nazanin Khakpour, MD, FACS Karen K. Fields, MD and their families.Surgical Oncology Medical Oncology/Hematology813-745-6300 813-745-6300 Our breast surgeons are leaders in breast-conservingnazanin.khakpour@moffitt.org karen.fields@moffitt.org surgery, nipple-sparing/skin-sparing mastectomy and sentinel lymph node mapping techniques which oftenJohn V. Kiluk, MD, FACS Hyo (Heather) S. Han, MDSurgical Oncology Medical Oncology/Hematology result in less invasive axillary surgery. Other therapies813-745-6300 813-745-6300 include breast-conservation therapy with intraoperativejohn.kiluk@moffitt.org hyo.han@moffitt.org breast irradiation (IORT), adjuvant or hormonal therapyChristine Laronga, MD, FACS Roohi R. Ismail-Khan, MD and the most current chemotherapy regimens. TheSurgical Oncology Medical Oncology latest techniques in plastic and reconstructive surgeryClinical Director, Breast 813-745-6300 are also available.Surgical Oncology roohi.ismail-khan@moffitt.org Radiology services include screening mammography,813-745-6300christine.laronga@moffitt.org [ Loretta S. Loftus, MD, MBA, FACP CAD (computer-aided detection), digital mammography, Medical Oncology/Hematology breast ultrasound, breast MRI and minimally invasive[ M. Catherine Lee, MD, FACS 813-745-6300 core biopsy (ultrasound-guided stereotactic and MRI-Surgical Oncology loretta.loftus@moffitt.org813-745-6300 guided).marie.lee@moffitt.org [ Susan E. Minton, DO Medical Oncology Research 813-745-6300 susan.minton@moffitt.org The Don and Erika Wallace Comprehensive BreastPLASTIC AND RECONSTRUCTIVESURGEONS Hatem Soliman, MD Program can offer a wide range of clinical trials to Medical Oncology/Hematology patients, including investigator-initiated studies,Deniz Dayicioglu, MD trials from national cooperative groups and selectPlastic and Reconstructive Surgery 813-745-6300813-745-6300 hatem.soliman@moffitt.org pharmaceutical studies. The program currently hasdeniz.dayicioglu@moffitt.org studies to evaluate neoadjuvant chemotherapy, surgical treatment options, treatment of metastatic disease andAnh H. Nguyen, MDPlastic and Reconstructive Surgery new breast imaging modalities. Additional investigations813-745-6300 focus on new risk markers and genetic screening. Toanh.nguyen2@moffitt.org refer a patient for possible participation in a clinicalPaul D. Smith, MD research study, contact the program at 813-745-1807.Plastic and Reconstructive Surgery813-745-6300paulsmith@drpaulsmith.comKaren E. Wells, MD, FACSPlastic and Reconstructive Surgery813-745-6300karen.wells@moffitt.org[ THESE PHYSICIANS ALSO SEE PATIENTS AT MOFFITT CANCER CENTER’S SATELLITE LOCATION NEAR INTERNATIONAL PLAZA.To refer a patient: 813-745-3980 or 1-888-860-2778, Mon-Fri, 8:00 am - 5:00 pmInformation about clinical trials: 813-745-4106 MOFFITT.org 9
  10. 10. CU TANEO U S O NCO LO GY PRO G RA M D E PA R T M E N T C H A I R A N D PROGRAM LEADER Vernon K. Sondak, MD Overview Surgical Oncology At Moffitt Cancer Center, we believe that cancer treatment is most 813-745-8788 effective when delivered by an integrated team of medical professionals vernon.sondak@moffitt.org who specialize in site-specific cancers. The Cutaneous Oncology Program, one of more than a dozen cancer treatment programs at the Cancer Center, specializes in the evaluation and treatment of SURGEONS D E R M AT O L O G I S T S patients with the most common skin cancers – basal and squamous Ricardo J. Gonzalez, MD Basil S. Cherpelis, MD cell carcinoma – as well as melanoma, Merkel cell cancers and other Surgical Oncology Dermatology/Mohs rare skin tumors. A multidisciplinary team of specialists provides a 813-745-6161 Micrographic comprehensive program of care for patients with all types of skin ricardo.gonzalez@moffitt.org Surgery cancer, especially melanoma – the most serious type. Screening, Amod A. Sarnaik, MD 813-974-4270 diagnosis, staging and treatment are provided, as well as long-term Surgical Oncology bcherpel@health.usf.edu follow-up. The program’s comprehensive care includes the latest in 813-745-8581 Neil A. Fenske, MD investigational treatments and research for melanoma. amod.sarnaik@moffitt.org Dermatology 813-974-4270 Florida has one of the highest rates of malignant melanoma and skin Vernon K. Sondak, MD cancer in the nation due to its southern location and high levels of Surgical Oncology nfenske@health.usf.edu ultraviolet radiation exposure, and also because its population includes 813-745-8788 L. Frank Glass, MD vernon.sondak@moffitt.org Dermatology/ older individuals with a lifetime of sun exposure. Roughly 5,000 new Dermatopathology cases of melanoma will be diagnosed in Florida; this figure accounts for Jonathan S. Zager, MD seven percent of the incidence rate for the entire country. Progress in Surgical Oncology 813-974-3744 fglass@health.usf.edu early detection and treatment has improved the cure rate of melanoma, 813-745-1085 jonathan.zager@moffitt.org Mary H. Lien, MD but because curability depends greatly on the thickness of the skin Dermatology tumor at diagnosis, early detection and aggressive surgical treatment 813-974-2188 are crucial. PLASTIC SURGEONS mlien@health.usf.edu The Cutaneous Oncology Program at Moffitt Cancer Center offers the [ C. Wayne Cruse, MD most current diagnostic procedures available, including lymphatic Plastic Surgery 813-844-8546 mapping and sentinel lymph node biopsy. All physicians in the wcruse@health.usf.edu Cutaneous Oncology Program collaborate in the evaluation and discussion of diagnostic test results and meet regularly to develop Gerard C. Mosiello, MD Plastic and Reconstructive Surgery therapeutic plans. The initial surgical biopsy results are confirmed 813-631-1500 by a dermatopathologist. Further evaluations may include computed jerry@tampapalmsplasticsurgery.com tomography (CT) scans and positron emission tomography (PET) scans, magnetic resonance imaging (MRI), and ultrasound of lymph node areas MEDICAL ONCOLOGISTS at risk for metastasis. Fine needle aspiration biopsies of regional lymph nodes and sites of possible metastasis may be used, if necessary. Ronald C. DeConti, MD Ragi R. Kudchadkar, MD Medical Oncology Medical Oncology With the incidence of skin cancer increasing in the state of Florida, 813-745-8788 813-745-8581 Moffitt Cancer Center established the Mole Patrol™, which provides free ronald.deconti@moffitt.org ragini.kudchadkar@moffitt.org skin cancer screening to Florida residents in partnership with Moffitt Geoffrey Gibney, MD Jeffrey S. Weber, MD, PhD affiliates around the state. The Mole Patrol helps to raise awareness Medical Oncology Medical Oncology/Immunology of the importance of early detection and prevention of skin cancer. 813-745-8482 Director, Donald A. Adam The Mole Patrol™ is often present at Florida’s beaches and public geoffrey.gibney@moffitt.org Comprehensive Melanoma events, including air shows and sporting events, offering a variety of David E. Jones, Jr, MD, PhD Research Center educational materials about sun safety to the public. Medical Oncology 813-745-2007 813-745-8482 jeffrey.weber@moffitt.org Research david.jones@moffitt.org The Cutaneous Oncology Program participates in clinical trials supported by Moffitt, the National Institutes of Health, cooperative groups and selected pharmaceutical companies. Since its inception in 1987, members of the Cutaneous Oncology Program have had an interest in immunotherapeutic approaches to the disease. A number of chemotherapy and immunotherapy protocols and even gene transfer studies are underway for patients with metastatic melanoma. Program members are collaborating with basic science researchers to increase [ THESE PHYSICIANS ALSO SEE PATIENTS AT MOFFITT our understanding of the biology and epidemiology of skin cancers and CANCER CENTER’S SATELLITE LOCATION NEAR devise new treatment approaches based on this knowledge. INTERNATIONAL PLAZA. To refer a patient with melanoma and nonmelanoma skin cancer: 813-745-1968 Information about clinical trials: 813-745-410610 Moffitt Medical Group
  11. 11. EN DOC RIN E T U MO R P RO G RA M PROGRAM LEADER W. Bradford Carter, MD, FACS, FACE Overview Surgical Oncology/Endocrine Surgery 813-745-1965 The Endocrine Tumor Program provides a full range of bradford.carter@moffitt.org services for all endocrine disorders. Moffitt physicians have extensive expertise in diagnosing and treating all endocrine disorders, both cancerous and benign. This clinic provides comprehensive evaluation and treatmentE N D O C R I N E S U G E RY planning of all endocrine disorders, including tumors ofW. Bradford Carter, MD, FACS, FACE the thyroid, parathyroid, pituitary and adrenal, as wellSurgical Oncology/Endocrine Surgery as endocrine effects of cancer, including osteoporosis.813-745-1965 We provide advanced treatment techniques in endocrinebradford.carter@moffitt.org surgery, such as laparoscopic adrenalectomy, minimally invasive and radio-guided parathyroidectomy, minimally invasive thyroidectomy, laparoscopic surgery forENDOCRINOLOGISTS islet cell tumor of the pancreas and microsurgeryHoward S. Lilienfeld, MD, FACP, FACE for pituitary tumors. We also provide world-classEndocrinologist specializing in pituitary, adrenal and thyroid disorders expertise in neuroendocrine tumors, multiple endocrineSection Chief, Endocrinology813-745-1965 neoplasias and other genetic endocrinopathies. Genetichoward.lilienfeld@moffitt.org counseling and testing are part of the diagnostic and treatment options available for these patients. WhileJohn B. Tourtelot, MD, FACP, FACE cancers of the endocrine glands are rare, the treatmentEndocrinology813-745-1965 requires special diagnostics and treatment.john.tourtelot@moffitt.org The Endocrine Tumor Program has expanded its surgery services to include da Vinci® Surgical System robotic- assisted surgery for the removal of adrenal tumors, including pheochromocytomas. Robotic-assisted thyroid surgery also is offered, and the procedure is performed through a transaxillary approach that does not require any neck incisions. Research Clinical and basic science research within the program is searching to advance treatment of thyroid and adrenocortical cancer and to define cancer interactions with endothelial cells and vascular tissues.[ THESE PHYSICIANS ALSO SEE PATIENTS AT MOFFITT CANCER CENTER’S SATELLITE LOCATION NEAR INTERNATIONAL PLAZA.To refer a patient: 813-745-3980 or 1-888-860-2778, Mon-Fri, 8:00 am - 5:00 pmInformation about clinical trials: 813-745-4106 MOFFITT.org 11
  12. 12. GASTROINT EST INAL O N CO LO GY PRO G RA M D E PA R T M E N T C H A I R A N D PROGRAM LEADER Overview [ Mokenge P. Malafa, MD, FACS Surgical Oncology The Gastrointestinal (GI) Oncology Program is a Head, Section of Hepatopancreatobiliary Oncology specialized interdisciplinary program that focuses on 813-745-1432 the treatment and prevention of cancers of the GI tract, mokenge.malafa@moffitt.org including colorectal, esophageal, liver, and pancreatic cancer. Our interdisciplinary team approach to patient SURGEONS MEDICAL ONCOLOGISTS care means that patients are seen by cancer specialists Sophie Dessureault, MD, PhD, FACS, Khaldoun Almhanna, MD, MPH with expertise in GI oncology. FRCS(C) Medical Oncology Surgical Oncology 813-745-7257 khaldoun.almhanna@moffitt.org Research Clerkship Director 813-745-3636 Lodovico Balducci, MD Currently, Moffitt Cancer Center is aggressively sophie.dessureault@moffitt.org Medical Oncology/Hematology developing new drugs to treat patients with cancers of Pamela J. Hodul, MD Program Leader, Senior Adult Oncology the GI system. A mission of the GI Oncology Program Surgical Oncology 813-745-8658 is to develop new treatments for diseases of the GI 813-745-1277 lodovico.balducci@moffitt.org tract. For many years, only a few select treatments pamela.hodul@moffitt.org William R. Dinwoodie, MD and drugs were available to treat GI tumors. In pursuit Richard C. Karl, MD, FACS Medical Oncology of the program’s mission, the GI team has developed Surgical Oncology 813-745-3636 william.dinwoodie@moffitt.org alliances with the National Cancer Institute’s Cancer 813-745-1277 Therapy Evaluation Program (CTEP), multi-institutional richard.karl@moffitt.org Martine Extermann, MD, PhD cooperative groups including the Southwest Oncology Medical Oncology [ Mokenge P. Malafa, MD, FACS Group (SWOG), the Moffitt Drug Discovery Program, and 813-745-3822 Surgical Oncology select pharmaceutical companies. The team focuses on martine.extermann@moffitt.org Head, Section of Hepatopancreatobiliary selecting drugs that have the ability to target tumor Oncology [ Jennifer L. Giglia, MD 813-745-1432 Medical Oncology cells with greater precision than standard drugs can. mokenge.malafa@moffitt.org 813-745-1622 Members of the GI Oncology Program strongly believe jennifer.giglia@moffitt.org this aggressive approach to finding new treatments will [ Kenneth L. Meredith, MD, FACS contribute to the prevention and cure of cancers of the Surgical Oncology Richard Kim, MD Head, Section of Esophagogastric Medical Oncology GI system. Oncology 813-745-1277 richard.kim@moffitt.org The GI Oncology Program has numerous open clinical 813-745-6898 trials, including phase I trials that give patients the kenneth.meredith@moffitt.org Larry K. Kvols, MD Medical Oncology opportunity to be treated with the newest drugs that David Shibata, MD, FACS show promise in the laboratory. In addition, physicians 813-745-7257 Surgical Oncology and scientists at Moffitt conduct basic science and larry.kvols@moffitt.org Head, Section of Colorectal Oncology 813-745-6898 Gregory M. Springett, MD, PhD clinical research related to GI cancers. The goal of david.shibata@moffitt.org Medical Oncology this translational research is to bring new knowledge 813-745-6898 and treatments to the patient as quickly as possible. Timothy J. Yeatman, MD, FACS gregory.springett@moffitt.org Surgical Oncology In addition to its own research programs, Moffitt also Executive Vice President & Founding Jonathan R. Strosberg, MD participates in numerous regional and national cancer Chief Scientific Officer, M2Gen Medical Oncology studies. 813-745-7292 Head, Section of Neuroendocrine timothy.yeatman@moffitt.org Oncology 813-745-7257 jonathan.strosberg@moffitt.org E N D OS CO P I C O N CO LO GY James S. Barthel, MD, FACP, Cynthia L. Harris, MD Jason B. Klapman, MD FACG, FASGE Gastroenterology Gastroenterology Gastroenterology 813-745-8361 813-745-8361 Head, Section of Endoscopic Oncology cynthia.harris@moffitt.org jason.klapman@moffitt.org 813-745-8361 James F. Helm, MD, PhD Shivakumar Vignesh, MD james.barthel@moffitt.org Gastroenterology Gastroenterology 813-745-8361 813-745-8361 james.helm@moffitt.org shivakumar.vignesh@moffitt.org [ THESE PHYSICIANS ALSO SEE PATIENTS AT MOFFITT CANCER CENTER’S SATELLITE LOCATION NEAR INTERNATIONAL PLAZA. To refer a patient: 813-745-3980 or 1-888-860-2778, Mon-Fri, 8:00 am - 5:00 pm Information about clinical trials: 813-745-410612 Moffitt Medical Group
  13. 13. G ENITOUR INA RY O NCO LO GY PRO G RA M D E PA RT M E N T C H A I R A N D PROGRAM LEADER Overview [ Julio M. Pow-Sang, MD Urologic Surgery The Genitourinary Oncology Program provides a highly 813-745-8418 specialized team of physicians from multiple fields of julio.powsang@moffitt.org cancer medicine whose expertise is treating patients with genitourinary malignancies. These include cancers of the male and female urinary systems (prostate,SURGEONS testicles, penis, kidneys, ureters and bladder). The goalsJorge L. Lockhart, MD of the practice are to provide state-of-the-art care andUrologic Surgery develop more effective therapies for patients.813-259-8702 Some urologic cancers, such as testicular cancer, nowjorge.lockhart@moffitt.org are treated successfully with chemotherapy. Others,[ Julio M. Pow-Sang, MD such as bladder cancer, are showing better response toUrologic Surgery new combinations of chemotherapy. New treatments for813-745-8418 kidney cancer include biological therapy, which uses thejulio.powsang@moffitt.org body’s own immune system to fight cancer.Wade J. Sexton, MDUrologic Surgery Several standard and new therapies are being studied813-745-8418 for their ability to lower the prostate-specific antigenwade.sexton@moffitt.org (PSA) and inhibit the spread of disease to the bonePhilippe E. Spiess, MD and other distant sites. Men whose PSA is rising afterUrologic Surgery prostatectomy, radioactive seed therapy, external813-745-8418 radiation, or testosterone deprivation with leuprolide,philippe.spiess@moffitt.org goserelin, or orchiectomy are candidates for the Genitourinary Medical Oncology clinic where dedicatedMEDICAL ONCOLOGISTS specialists are studying new treatments for prostate cancer.Mayer N. Fishman, MD, PhDMedical Oncology An additional focus of the program is to respond to813-745-8418 the needs of patients of advanced age with advancedmayer.fishman@moffitt.org prostate cancer. The needs and desires of older patients[ Shilpa Gupta, MBBS (MD) can differ from those of younger patients. For example,Medical Oncology younger patients often choose the most effective813-745-8418 available therapies and place little emphasis on potentialshilpa.gupta@moffitt.org side effects. The Genitourinary Oncology Program worksJulie A. Kish, MD, FACP closely with the Senior Adult Oncology Program toMedical Oncology provide care and develop treatments for older patients.813-745-3822julie.kish@moffitt.org Moffitt urologic surgeons use the da Vinci® Surgical System to perform robotic-assisted surgery for patientsJingsong Zhang, MDMedical Oncology with prostate, kidney and bladder cancers. Dr. Pow-Sang813-745-8418 has experience using robotic-assisted surgery to performjingsong.zhang@moffitt.org retroperitoneal lymph node dissection to remove abdominal lymph nodes in treating testicular cancer. Research Physicians in the Genitourinary Oncology Program are actively involved in national and Moffitt-generated clinical studies, as well as laboratory research projects that may yield the new urologic cancer treatments of tomorrow. When appropriate, patients can participate in clinical studies that seek to take a standard treatment and improve its tolerability or efficacy. These studies use the newest and most promising cancer treatments and drugs.[ THESE PHYSICIANS ALSO SEE PATIENTS AT MOFFITT CANCER CENTER’S SATELLITE LOCATION NEAR INTERNATIONAL PLAZA.To refer a patient: 813-745-3980 or 1-888-860-2778, Mon-Fri, 8:00 am - 5:00 pmInformation about clinical trials: 813-745-4106 MOFFITT.org 13
  14. 14. Th e Ce nte r For Wom e n’s O n co lo g y : GY NECO LOGIC ONCOLOGY P RO GRA M D E PA RT M E N T C H A I R PROGRAM LEADER DIRECTOR, THE CENTER FOR Overview WOMEN’S ONCOLOGY The Gynecologic Oncology Program specializes in Johnathan M. Lancaster, MD, PhD, FACS, FACOG the treatment and evaluation of women with ovarian, Women’s Oncology and Gynecologic Oncology cervical, endometrial, vulvar, or vaginal cancers or 813-745-6300 gestational trophoblastic disease. johnathan.lancaster@moffitt.org Research GY N ECO LO G I C O N CO LO G I STS Clinicians and basic researchers regularly collaborate Sachin M. Apte, MD to discover more effective therapies for gynecologic Gynecologic Oncology cancers. The program has active translational and 813-745-6300 clinical research protocols, including the application of sachin.apte@moffitt.org genomics to develop personalized therapy for ovarian [ Jesus Gonzalez Bosquet, MD, PhD, FACOG cancer. The program enrolls patients in active phase I, Gynecologic Oncology II and III clinical trials for gynecologic malignancies. In 813-745-6300 addition to its own research programs, Moffitt Cancer jesus.gonzalezbosquet@moffitt.org Center participates in many regional and national [ Patricia L. Judson, MD cancer treatment studies, including those offered by the Gynecologic Oncology Gynecologic Oncology Group (GOG). The Gynecologic 813-745-6300 Oncology Program at Moffitt is the site of the principal patricia.judson@moffitt.org investigative body of the Tampa Bay Cancer Consortium, Johnathan M. Lancaster, MD, PhD, FACS, FACOG an organization of hospitals and universities involved in Gynecologic Oncology GOG research. 813-745-6300 johnathan.lancaster@moffitt.org William S. Roberts, MD, FACS, FACOG Gynecologic Oncology 813-745-6300 william.roberts@moffitt.org Robert M. Wenham, MD, FACS, FACOG Gynecologic Oncology 813-745-6300 robert.wenham@moffitt.org [ THESE PHYSICIANS ALSO SEE PATIENTS AT MOFFITT CANCER CENTER’S SATELLITE LOCATION NEAR INTERNATIONAL PLAZA. To refer a patient: 813-745-3980 or 1-888-860-2778, Mon-Fri, 8:00 am - 5:00 pm Information about clinical trials: 813-745-410614 Moffitt Medical Group
  15. 15. H EA D AND NEC K O NCO LO GY PRO G RA M PROGRAM LEADER Thomas V. McCaffrey, MD, PhD Overview Otolaryngology 813-745-3057 The Head and Neck Oncology Program provides thomas.mccaffrey@moffitt.org comprehensive, patient-oriented care for all types and stages of head and neck cancer and thyroid cancer, with special attention to preservation, quality of life, rehabilitation and education. Physicians and staff areS U R G I C A L O N C O L O G Y/ S K U L L B A S E M A X I L L O FA C I A L dedicated to providing the newest and most effectiveS U R G E R Y/ T H Y R O I D D I S O R D E R S PROSTHETICS care to patients while striving to blend compassion andKathryn L. Hall, MD Terry M. Kelly, DMD, PA technique in their care approach.Otolaryngology Reconstructive & Implant Services include all phases of care ranging from813-250-2216 Prosthodontics diagnosis and treatment to reconstruction andkhall@health.usf.edu 813-971-0620 terry.kelly@verizon.net rehabilitation. With a focus on preservation andJudith C. McCaffrey, MD rehabilitation, the program offers plastic andOtolaryngology reconstructive surgery, microvascular free-tissue813-745-8363judith.mccaffrey@moffitt.org OTO L A RY N G O LO G I STS transfer, maxillofacial prosthodontics, extensive Alec Beningfield, MD speech and swallowing rehabilitation and psychosocialThomas V. McCaffrey, MD, PhD OtolaryngologyOtolaryngology consultation. Expertise in the diagnosis and treatment 813-974-6573 of complex skull base tumors is provided through813-745-3057 abeningf@health.usf.edu the Center for Skull Base Oncology at Moffitt, anthomas.mccaffrey@moffitt.org Marion B. Ridley, MD interdisciplinary effort between the Neuro-Oncology andTapan A. Padhya, MD OtolaryngologyOtolaryngology Head and Neck Oncology Programs. 813-974-4706813-745-8363 mridley@health.usf.edu Researchtapan.padhya@moffitt.org Mark H. Tabor, MDFrank D. Vrionis, MD, MPH, PhD Clinicians and basic scientists work together to discover OtolaryngologyNeurological Surgery new treatments and cures for head and neck cancers. 813-250-2216Chief of Neurosurgery This translational approach to research brings together mtabor@health.usf.edu813-745-4251 the best in research from both clinical and laboratoryfrank.vrionis@moffitt.org perspectives. Members of the Head and Neck Oncology HEAD AND NECK MEDICAL Program participate in national, regional and industry- ONCOLOGISTSO T O L O G Y/ N E U R O T O L O G Y/ based clinical trials. Current trials include:L AT E R A L S K U L L B A S E Ronald C. DeConti, MDS U RG E RY Medical Oncology • Phase II and phase III trials for advanced 813-745-8466 metastatic or recurrent cancers of the head andK. Paul Boyev, MD neck of squamous cell origin ronald.deconti@moffitt.orgOtolaryngology813-974-6573 Julie A. Kish, MD, FACP • The latest chemotherapy trials includingpboyev@health.usf.edu Medical Oncology tamoxifen and docetaxel 813-745-3822 julie.kish@moffitt.orgHEAD AND NECK Tawee Tanvetyanon, MDM I C R O VA S C U L A R Medical OncologyRECONSTRUCTION 813-745-8477Mark El-Deiry, MD tawee.tanvetyanon@moffitt.orgOtolaryngology813-745-8363mark.eldeiry@moffitt.org[ THESE PHYSICIANS ALSO SEE PATIENTS AT MOFFITT CANCER CENTER’S SATELLITE LOCATION NEAR INTERNATIONAL PLAZA.To refer a patient: 813-745-3980 or 1-888-860-2778, Mon-Fri, 8:00 am - 5:00 pmInformation about clinical trials: 813-745-4106 MOFFITT.org 15
  16. 16. IN TE RNAL A ND HOS P I TA L M E D I CI N E PRO G RA M PROGRAM LEADER Debra L. Anoff, MD, FACP Overview Internal and Hospital Medicine 813-745-3134 The Internal and Hospital Medicine (IHM) Program debra.anoff@moffitt.org focuses on medical conditions that interact with a patient’s cancer management. We manage other diseases that may be present during care at Moffitt, such as diabetes, heart and lung problems, infections INTERNISTS and other complications. In addition, program Debra L. Anoff, MD, FACP physicians provide care to hospitalized patients, work Internal and Hospital Medicine with surgeons to identify and reduce surgical risk and 813-745-3134 coordinate care with subspecialists. Functioning largely debra.anoff@moffitt.org as hospitalists, the IHM physicians also oversee Moffitt’s Susmitha Apuri, MD Direct Referral Center for urgent problems and maintain Internal and Hospital Medicine active clinics for follow-up on inpatients, high-risk 813-745-4119 preoperative patients and a variety of other noncancer susmitha.apuri@moffitt.org patient needs including anticoagulation management. Bryan A. Bognar, MD, MPH, FACP Internal and Hospital Medicine Research 813-745-3134 bryan.bognar@moffitt.org Physicians in the IHM Program play major administrative and teaching roles with students and residents at the Kristin Carlin, DO Internal and Hospital Medicine University of South Florida College of Medicine. They 813-745-3134 have contributed to national medical textbooks, have kristin.carlin@moffitt.org published in a number of different areas, and are Lucy Guerra, MD, MPH, FACP recognized as leaders in medical education. Internal and Hospital Medicine 813-745-3134 lucy.guerra@moffitt.org Ebone’ Hill, MD Internal and Hospital Medicine 813-745-4119 ebone.hill@moffitt.org Bjorn Holmstrom, MD Internal and Hospital Medicine 813-745-3134 bjorn.holmstrom@moffitt.org Smitha Pabbathi, MD Internal and Hospital Medicine 813-745-4119 smitha.pabbathi@moffitt.org Carlos Palacio, MD Internal and Hospital Medicine 813-745-4119 carlos.palacio@moffitt.org [ THESE PHYSICIANS ALSO SEE PATIENTS AT MOFFITT CANCER CENTER’S SATELLITE LOCATION NEAR INTERNATIONAL PLAZA. To refer a patient: 813-745-3980 or 1-888-860-2778, Mon-Fri, 8:00 am - 5:00 pm Information about clinical trials: 813-745-410616 Moffitt Medical Group
  17. 17. M A L IGNA NT HE MATO LO GY PRO G RA M D E PA RT M E N T C H A I R A N D PROGRAM LEADER Overview Eduardo M. Sotomayor, MD Medical Oncology The Malignant Hematology Program specializes in 813-745-1387 the evaluation, treatment, and comprehensive care of eduardo.sotomayor@moffitt.org patients with lymphoma, leukemia, multiple myeloma, myelodysplastic syndrome, and myeloproliferative syndrome. The program is recognized as a Center ofMEDICAL ONCOLOGISTS AND Jeffrey E. Lancet, MD Excellence by the Myelodysplasia (MDS) FoundationH E M AT O L O G I S T S Hematology, Medical Oncology and is one of four founding institutions of the BoneMelissa Alsina, MD Section Head, Leukemia/ Marrow Failure (BMF) Consortium funded by theHematology Myelodysplasia National Institutes of Health. All patients with MDS,813-745-7202 813-745-6841 jeffrey.lancet@moffitt.org large granular lymphocytic leukemia, aplastic anemia ormelissa.alsina@moffitt.org other rare causes of bone marrow failure are registeredLodovico Balducci, MD Alan F. List, MD in the Consortium’s national database, which wasHematology, Medical Oncology Hematology, Medical Oncology Executive Vice President, developed and is maintained at Moffitt Cancer Center.Program Leader, Senior Adult Oncology813-745-8658 Clinical Sciences The BMF Consortium is the first and only cooperativelodovico.balducci@moffitt.org Physician-In-Chief network developed by the National Institutes of Health President, Moffitt Medical Group for the study of the biology and development of novelRachid Baz, MD 813-745-6086Hematology, Medical Oncology therapeutics for these disorders. alan.list@moffitt.orgSection Head, Myeloma Although chemotherapy remains an integral813-745-8212 Javier Pinilla-Ibarz, MD, PhD component of the treatment for most hematologicrachid.baz@moffitt.org Hematology, Medical Oncology 813-745-1387 malignancies, the development of disease-specificCeleste Bello, MD javier.pinilla@moffitt.org or targeted therapeutics represents the researchHematology, Medical Oncology goal of Moffitt investigators who treat patients with813-745-4294 Hussain I. Saba, MD, PhD Hematology lymphoma, leukemias, and multiple myeloma. Marrowceleste.bello@moffitt.org 813-972-7582 or stem cell transplantation often is indicated for the[ Salvador Bruno, MD hussain.saba@moffitt.org treatment of hematologic malignancies. The treatmentMedical Oncology Bijal Shah, MD protocols of the Malignant Hematology Program813-745-1622salvador.bruno@moffitt.org Medical Oncology, Hematology are integrated with those of the Blood and Marrow 813-745-8212 Transplantation Program. The Cancer Center has state-[ Paul A. Chervenick, MD bijal.shah@moffitt.org of-the-art facilities for both inpatient and outpatientHematologyMedical Director, Moffitt Cancer Center Kenneth Shain, MD, PhD administration of chemotherapy.at International Plaza Medical Oncology813-745-1622 813-745-6841 Researchpaul.chervenick@moffitt.org ken.shain@moffitt.org Research is ongoing in basic research laboratories,Jennifer Cultrera, MD Lubomir Sokol, MD, PhD where scientists are investigating how the diseasesMedical Oncology Hematology, Medical Oncology originate, and in clinical investigations, where phase813-745-4294 Section Head, Lymphoma I and phase II studies are developed to introduce newjennifer.cultrera@moffitt.org 813-745-8212 lubomir.sokol@moffitt.org drug therapies that can directly impact patient care.William S. Dalton, PhD, MD The program emphasizes translational studies in whichMedical Oncology Eduardo M. Sotomayor, MD the trials are designed by Moffitt investigators based onPresident/CEO and Center Director Medical Oncology 813-745-1387 their preclinical findings. Moffitt investigators have led813-745-4261william.dalton@moffitt.org eduardo.sotomayor@moffitt.org the development of several promising new molecules that may alter the management of patients with theseMartine Extermann, MD, PhD Kenneth S. Zuckerman, MD Hematology diseases.Medical OncologySenior Adult Oncology Program 813-745-8090813-745-3822 ken.zuckerman@moffitt.orgmartine.extermann@moffitt.orgRami S. Komrokji, MDHematology, Medical OncologyClinical Director813-745-4294rami.komrokji@moffitt.org[ THESE PHYSICIANS ALSO SEE PATIENTS AT MOFFITT CANCER CENTER’S SATELLITE LOCATION NEAR INTERNATIONAL PLAZA.To refer a patient: 813-745-3980 or 1-888-860-2778, Mon-Fri, 8:00 am - 5:00 pmInformation about clinical trials: 813-745-4106 MOFFITT.org 17
  18. 18. N EURO-O NCO LO GY P RO G RA M D E PA RT M E N T C H A I R A N D PROGRAM LEADER Overview [ Peter A. Forsyth, MA, MD Neuro-Oncology The Neurosurgery and Neuro-Oncology Department is committed 813-745-3200 to providing the best possible care for complex tumors of the brain peter.forsyth@moffitt.org and spine. Moffitt is committed to creating new standards to provide optimal outcomes to our patients with tumors of the central nervous system, including primary (glioma) and secondary (metastatic) cancer, NEUROLOGICAL SURGEONS as well as benign tumors of the skull base (pituitary tumors, acoustic Surbhi Jain, MD neuromas, meningiomas). Advanced neuroimaging, including fiber Neurological Surgery tracking and motor mapping, defines the eloquent areas of the brain 813-745-3200 and provides optimal surgical outcomes. Patients receive intensive, surbhi.jain@moffitt.org personalized care and are followed with our referring physicians for Donald A. Smith, MD lifetime surveillance. Tumors formerly considered inoperable can be Neurological Surgery safely removed using minimally invasive techniques. 813-259-0633 Surgery is complemented by the Novalis stereotactic radiosurgery unit dosmith52@yahoo.com for metastatic cancer and for skull base tumors. The Neuro-Oncology Nam D. Tran, MD, PhD Program is recognized by the National Cancer Institute (NCI) as a Neurological Surgery founding and active member of the Adult Brain Tumor Consortium 813-745-3200 nam.tran@moffitt.org (ABTC, formerly NABTT), the only ABTC center in Florida that has a continual offering of new protocols from the NCI. Moffitt is a pioneer Frank D. Vrionis, MD, MPH, PhD in the integration of biological, molecular-targeted therapy, including Neurological Surgery Chief of Neurosurgery antiangiogenic molecules such as bevacizumab (Avastin), cilengitide, 813-745-3200 sunitinib (Sutent), cediranib (Recentin), sorafenib (Nexavar), HDAC frank.vrionis@moffitt.org inhibitors, vorinostat (Zolinza) and PARP inhibitors. We also are evaluating the use of chemotherapeutic wafers to obtain control of local tumors. For patients with glioblastoma, the dendritic cell vaccine NEURO-ONCOLOGISTS has shown promise. In concert with Moffitt Total Cancer Care™, we are [ Peter A. Forsyth, MA, MD committed to provide the most comprehensive, customized care for our Neuro-Oncology patients. 813-745-3200 peter.forsyth@moffitt.org For patients with spine tumors, Moffitt offers spinal stabilization to [ Edward Pan, MD preserve neural function and improve quality of life. We emphasize Neuro-Oncology minimally invasive techniques, such as retropleural thoracotomies, 813-745-3200 short segment fusions and the use of cages, to enhance fusion. edward.pan@moffitt.org Procedures such as kyphoplasty and vertebroplasty are available to reconstruct compressed vertebral bone, restore alignment or remove pressure on a nerve. NEUROLOGISTS Edward Bass, MD Research Neurology 813-745-3200 The Neuro-Oncology Program is built on strong clinical and basic edward.bass@moffitt.org science research programs, uniting scientists in the fields of neurosciences, molecular genetics, developmental neurobiology, cancer biology, bioinformatics and epidemiology to understand how and why OTHER SPECIALISTS tumors develop in the central nervous system, as well as to uncover the Howard S. Lilienfeld, MD, FACP, FACE mechanisms that result in tumor growth and resistance to therapy. The Endocrinologist specializing in pituitary, Brain Tumor Research Laboratory focuses on antiangiogenesis and the adrenal and thyroid disorders development of other novel forms of adjuvant therapy for malignant 813-745-7257 howard.lilienfeld@moffitt.org brain tumors. Collaborative research includes investigation of the root causes of brain tumor invasive spread and antiangiogenesis while developing the next generation of safe, effective drugs to be integrated with surgery, radiation therapy and chemotherapy. [ THESE PHYSICIANS ALSO SEE PATIENTS AT MOFFITT CANCER CENTER’S SATELLITE LOCATION NEAR INTERNATIONAL PLAZA. To refer a patient: 813-745-3980 or 1-888-860-2778, Mon-Fri, 8:00 am - 5:00 pm Information about clinical trials: 813-745-410618 Moffitt Medical Group
  19. 19. PSYC HOSO C IAL A ND PA L L I AT I V E CA RE PRO G RAM PROGRAM LEADER Bryan A. Bognar, MD, MPH, FACP Overview Internal and Hospital Medicine 813-745-3134 The Psychosocial and Palliative Care Program is bryan.bognar@moffitt.org engaged in clinical care, training and research designed to address the emotional, social, spiritual and physical needs of people being treated for cancer. Clinical services are provided by an interdisciplinary teamP A L L I AT I V E C A R E P S Y C H I AT R Y composed of professionals with expertise in palliativeSorin Buga, MD Margarita Bobonis Babilonia, MD care, psychiatry, clinical psychology, pharmacy, socialInternal Medicine Psychiatry work and chaplaincy. Psychosocial care is initiated with813-745-6853 813-745-8483 a screening procedure designed to elicit patient and/sorin.buga@moffitt.org margarita.bobonis@moffitt.org or family concerns, identify informational and resourceShirley N. Codada, MD Shirley Kocur, MD needs and review psychological and social factors thatInternal Medicine; Hospice and Psychiatry could potentially interfere with the optimal delivery ofPalliative Care 813-745-8483 care. Additional components of the Psychosocial and813-745-6853 shirley.kocur@moffitt.org Palliative Care Program include Integrative Medicine.shirley.codada@moffitt.org Marguerite Pinard, MD Integrative Medicine at Moffitt offers many healingSahana Rajasekhara, MD Psychiatry and wellness services, and integrates safe, effectiveInternal Medicine; Geriatric Medicine 813-745-6052813-745-6853 marguerite.pinard@moffitt.org therapies to complement conventional treatmentssahana.rajasekhara@moffitt.org and to improve the quality of life for patients during and after cancer treatment. Integrative Medicine also conducts research on therapies and incorporatesC L I N I C A L P SYC H O LO GY the latest advances into patient care to reduce theMargaret Booth-Jones, PhD side effects and symptoms associated with cancerClinical Psychology treatments. The broad range of services include813-745-6052 yoga, tai chi, meditation, guided imagery andmargaret.booth-jones@moffitt.org relaxation therapy, inpatient and outpatient massageKristine A. Donovan, PhD, MBA therapy, acupuncture, nutrition and pharmaceuticalClinical Psychology consultations.813-745-6052kristine.donovan@moffitt.org ResearchPaul B. Jacobsen, PhDClinical Psychology Research efforts are in palliative care and psychosocial813-745-1810 oncology. The aims of the research program are topaul.jacobsen@moffitt.org understand and influence human behavior for theSarah Rausch, PhD, LP purposes of promoting cancer prevention and control asDirector of Integrative Medicine well as symptom management. Current projects focus813-745-6052 on developing psychosocial interventions to enhancesarah.rausch@moffitt.org quality of life, identifying factors associated withLora M. A. Thompson, PhD support group participation and investigating processesClinical Psychology involved in patient decision making about cancer813-745-6052 treatment. Additionally, Integrative Medicine trialslora.thompson@moffitt.org designed to better understand outcomes for cancer patients are offered; these trials utilize a variety of complementary, alternative, and integrative therapies.[ THESE PHYSICIANS ALSO SEE PATIENTS AT MOFFITT CANCER CENTER’S SATELLITE LOCATION NEAR INTERNATIONAL PLAZA.To refer a patient: 813-745-3980 or 1-888-860-2778, Mon-Fri, 8:00 am - 5:00 pmInformation about clinical trials: 813-745-4106 MOFFITT.org 19
  20. 20. RA D IATIO N O NCO LO GY D E PA RT M E N T D E PA R T M E N T C H A I R [ Craig W. Stevens, MD, PhD Overview Radiation Oncology/Thoracic Oncology 813-745-8424 The Radiation Oncology Department provides highly craig.stevens@moffitt.org specialized teams of physicians who have tumor-specific expertise in the treatment of all tumor/organ sites and a broad array of cutting-edge technologies. This allows for expert radiotherapy treatment planning and delivery MEMBERS Robert S. Lavey, MD, MPH that is personalized to each patient’s needs, as well as Matthew C. Biagioli, MD Radiation Oncology/Pediatrics/ skilled management of radiation side effects. This care Radiation Oncology/Brachytherapy Hematologic Services can be accessed by referral through the appropriate Genitourinary Oncology 813-745-8424 multidisciplinary program, or by direct referral to 813-745-8424 robert.lavey@moffitt.org Radiation Oncology. Radiation treatment modalities matthew.biagioli@moffitt.org [ Ravi Shridhar, MD, PhD include: Jimmy J. Caudell, MD, PhD Radiation Oncology/ • 3-dimensional computerized radiation therapy Radiation Oncology/Cutaneous, Gastrointestinal Oncology 813-745-8424 (3D CRT) Head and Neck Oncology 813-745-3547 ravi.shridhar@moffitt.org • Intensity-modulated radiation therapy (IMRT) jimmy.caudell@moffitt.org [ Craig W. Stevens, MD, PhD • Image-guided radiotherapy (IGRT) using Prakash Chinnaiyan, MD Radiation Oncology/ TomoTherapy®, Novalis, Trilogy, TrueBeam™ Radiation Oncology/ Thoracic Oncology technologies Neuro-Oncology 813-745-8424 craig.stevens@moffitt.org • Tumor motion management with 4D-CT and 813-745-8424 prakash.chinnaiyan@moffitt.org 4D-PET/CT, and respiratory gating [ Michael B. Tomblyn, MD, MS Candace R. Correa, MD, BS Radiation Oncology/ • Stereotactic radiotherapy (SRT) and stereotactic Radiation Oncology/Breast Radiopharmaceuticals/Hematologic radiosurgery (SRS): to the brain, spine, lung, liver, Oncology, Gynecologic Oncology Services pancreas and metastatic sites 813-745-4142 813-745-8424 • Advanced brachytherapy for many organ sites candace.correa@moffitt.org michael.tomblyn@moffitt.org • Accelerated partial breast irradiation (APBI) with Thomas J. Dilling, MD Javier F. Torres-Roca, MD Radiation Oncology/ brachytherapy or 3D CRT Radiation Oncology/ Thoracic Oncology Genitourinary Oncology • IntraBeam® intraoperative breast radiotherapy 813-745-8424 813-745-8424 • Theraspheres® for the treatment of liver thomas.dilling@moffitt.org javier.torresroca@moffitt.org metastases [ Sophia Edwards-Bennett, MD, PhD Andrea “Andy” M. Trotti III, MD • Radiolabeled monoclonal antibody therapy of Radiation Oncology/Breast Radiation Oncology/Cutaneous, lymphoma: ibritumomab tiuxetan (Zevalin), Oncology, Gynecologic Oncology Head and Neck Oncology 813-745-8424 tositumomab (Bexxar), and other novel agents for 813-745-8424 Sophia.EdwardsBennett@moffitt.org andy.trotti@moffitt.org the treatment of prostate cancer and metastases Eleanor E.R. Harris, MD [ Richard B. Wilder, MS, MD, MBA Clinical Director Radiation Oncology/ Radiation Oncology/Breast Genitourinary Oncology Research Oncology, Gynecologic Oncology 813-745-8434 The Radiation Oncology Department participates as 813-745-8424 richard.wilder@moffitt.org a full-member institution of the Radiation Therapy eleanor.harris@moffitt.org Hsiang-Hsuan Michael Yu, MD, ScM Oncology Group (RTOG) and has many national Randy V. Heysek, MD Radiation Oncology/ protocols open for enrollment at Moffitt Cancer Radiation Oncology/Prostate Neuro-Oncology Center. Moffitt faculty serve as principal investigators Seed Implants 813-745-8424 michael.yu@moffitt.org or co-investigators on several RTOG trials and have 813-745-8424 investigator-initiated trials open in head and neck, randy.heysek@moffitt.org breast, lymphoma, gastrointestinal, brain and other [ Sarah Hoffe, MD cancers. Numerous innovative investigator-initiated Radiation Oncology/ trials are also open, with information available by Gastrointestinal Oncology Director of Physician Services, Moffitt request from the chair. Cancer Center at International Plaza 813-745-8424 sarah.hoffe@moffitt.org [ THESE PHYSICIANS ALSO SEE PATIENTS AT MOFFITT CANCER CENTER’S SATELLITE LOCATION NEAR INTERNATIONAL PLAZA. To refer a patient: 813-745-3980 or 1-888-860-2778, Mon-Fri, 8:00 am - 5:00 pm Information about clinical trials: 813-745-410620 Moffitt Medical Group

×